Natera Q3 Revenue Jumps 34% to $794M; Net Loss Narrows to $59.9M
NTRA sits 62% above its 52-week low of $181 on elevated volume (2.0× avg).
Summary
Natera reported Q3 2026 revenue of $794.0 million, up 34.1%, with the net loss narrowing to $59.9 million and $1.097 billion in cash. The 10-Q also discloses a CEO change effective November 5, 2026 and a $30.0 million acquisition of a strategic partner.
Key Events · Earnings and Guidance · NTRA
-
Q3 Revenue Up 34.1% to $794M
Total revenues were $793.981 million versus $592.183 million a year ago, driven by higher test volumes and a higher average selling price.
-
Net Loss Narrows to $59.9M
Q3 2026 net loss was $59.9 million versus $87.5 million a year ago; nine-month net loss was $212.0 million versus $255.4 million.
-
Cash of $1.097B, $80.3M Drawn
Cash, cash equivalents and restricted cash totaled $1.097 billion at September 30, 2026, with $80.3 million outstanding on the UBS credit line and $20.0 million remaining available.
-
CEO Transition Effective November 5
Steve Chapman resigned and Solomon Moshkevich was appointed CEO and President effective November 5, 2026; Chapman receives a $1,000,000 lump-sum transition payment and a $1,500,000 target 2026 bonus.
Analysis · NTRA · Industrial Applications And Services
Revenue growth of 34.1% with gross margin holding at 64.7% shows the Signatera-led oncology ramp is scaling without margin erosion, and the net loss narrowed to $59.9 million from $87.5 million a year ago. The balance sheet remains strong with $1.097 billion in cash against only $80.3 million drawn on the UBS credit line, so there is no near-term financing pressure. Two subsequent events matter for the thesis: a new CEO (Solomon Moshkevich, effective November 5, 2026) and a small $30.0 million acquisition of a strategic partner on November 2, 2026.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NTRA was trading at $293.97 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $52.4B. The 52-week trading range was $181.00 to $437.41. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.